Hologic Recalls Brevera Breast Biopsy System Due to Contamination Hazard
Hologic, Inc. recalled 681,870 units of the Brevera Breast Biopsy System on December 15, 2025, due to presence of particulates that can enter breast tissue. The recall affects devices distributed nationwide in the U.S. Healthcare providers and patients must stop using the device immediately.
Quick Facts at a Glance
Recall Date
December 15, 2025
Hazard Level
HIGH
Brand
Hologic
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Presence of particulates in affected devices that can be deposited into breast tissue during use.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Hologic, Inc or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The Brevera Breast Biopsy System is a medical device used for breast biopsies. It aids in the accurate sampling of breast tissue for diagnostic purposes.
Why This Is Dangerous
The device has been found to contain particulates that can enter breast tissue during a biopsy, posing potential health risks.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Patients are advised to stop using the device immediately, which may lead to delays in necessary medical procedures.
Practical Guidance
How to identify if yours is affected
Locate the model number on the device.
Check for the UDI number on the packaging.
Confirm the device is within the recalled lot.
Where to find product info
Model numbers and UDI can typically be found on the device packaging or in the user manual.
What timeline to expect
Expect a response from Hologic within 4-6 weeks for refund processing.
If the manufacturer is unresponsive
Contact Hologic customer service again.
Document all communications regarding the recall.
Consider reporting to the FDA if unresponsive.
How to prevent similar issues
Look for FDA recall alerts on medical devices.
Check for safety certifications before purchasing medical devices.
Consult healthcare professionals about device safety.
Documentation advice
Keep a record of any communication regarding the recall, including emails and letters from the manufacturer.
Product Details
The Brevera Breast Biopsy System includes a Disposable 9 Gauge Needle. Model numbers affected are BREVDISP09 and UDI 1540045512863. The devices were distributed nationwide.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.